HMDS Laboratory, St James's Institute of Oncology, Leeds.
Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):176-9. doi: 10.3816/CLML.2011.n.042.
Histological transformation, typically to diffuse large B-cell lymphoma (DLBCL) is reported to occur in 5%-10% of patients with WM and recent studies have highlighted a possible aetiological role for the nucleoside analogues. It is however becoming increasingly clear that histological transformation is a complex phenomenon and may include clonally unrelated disorders. In order to highlight this pathological heterogeneity we describe 5 patients with diverse histological progression events. These included EBV-associated events namely DLBCL, peripheral T-cell lymphoma and spontaneously resolving mucocutaneous ulcer. A further 2 patients demonstrated a localised plasma cell rich lesion simulating plasmacytoma and a de novo DLBCL arising in an unrelated B-cell clone. It is clear therefore that detailed pathological assessments are required in all suspected cases of transformation and that the pathological heterogeneity demonstrated by this study needs to be taken into account when potential aetiological factors are being assessed.
组织学转化,通常转化为弥漫性大 B 细胞淋巴瘤(DLBCL),据报道在 5%-10%的 WM 患者中发生,最近的研究强调了核苷类似物可能的病因作用。然而,越来越明显的是,组织学转化是一种复杂的现象,可能包括克隆无关的疾病。为了突出这种病理异质性,我们描述了 5 例具有不同组织学进展事件的患者。这些事件包括 EBV 相关事件,即 DLBCL、外周 T 细胞淋巴瘤和自发缓解的黏膜溃疡。另外 2 例患者表现为局灶性富含浆细胞的病变,类似于浆细胞瘤,以及在无关 B 细胞克隆中发生的新发性 DLBCL。因此,很明显,在所有疑似转化的病例中都需要进行详细的病理评估,并且本研究中表现出的病理异质性在评估潜在病因因素时需要考虑在内。